Reports of neurological toxicity of cryopreserved stem cell infusion are infrequent. Three of 179 consecutive patients experienced significant neurological events in this context. Transient global amnesia developed following infusion in one patient and in the other two, cerebral infarction occurred. Profound hypotension, bradyarrhythmias or hypoxia were not associated with any of these episodes. These events may have been related to infused DMSO, which in the non-transplant setting has been associated with neurological toxicity and local infusion of which has resulted in acute vasospasm in animal models. These cases suggest that infusion of cryopreserved stem cells may result in cerebrovascular ischaemia. Bone Marrow Transplantation (2000) 25, 1285-1287.
Common toxicities associated with the infusion of cryopreserved bone marrow (BM) or peripheral blood progenitor cells (PBPC) include nausea, vomiting, chills and rigors. [1] [2] [3] Alessandrino et al 1 in an analysis of 126 infusions found an appreciable incidence of cardiovascular complications, particularly bradyarrhythmias, after BM/PBPC infusions but this and other studies have not documented neurological toxicities other than the occurrence of headache. 2 This report describes significant neurological events associated with the infusion of BM and/or PBPC cryopreserved with 10% dimethylsulfoxide (DMSO), in three of 179 consecutive patients undergoing infusions of autologous BM (n = 4), PBPC (n = 159) or both (n = 16) between January 1995 and August 1999.
Case reports
Descriptive details of the patients, transplants and neurologic events are listed in Table 1 . 
Case 1
At the completion of busulfan therapy, mild twitching occurred and subsequently resolved by day −1. Four bags of BM and four of PBPC were infused after which he experienced some vomiting and 3 h later became febrile (38°C). No antibiotics were given and blood cultures were negative. Eight hours after infusion he was noted to be alert but could not recall any details about his hospitalisation and diagnosis. There were no focal neurological deficits. An ECG at the time and a CT scan done 12 h later were both normal. The following day he was orientated to time, place and person but could not recall the events of the previous week; memory for distant events was preserved. A diagnosis of transient global amnesia was made. The remainder of the transplant admission was uneventful. He had not formed any memories of the stem cell infusion by the time of his death 6 months later.
Case 2
A single bag of PBPC was infused and the platelet count on the morning of infusion was 60 × 10 9 /l. Twenty minutes after the completion of the infusion, the patient became confused, vomited and was incontinent. She remained normotensive and in sinus rhythm. There were no focal neurological signs and a CT scan done 2 h later was normal. On the day after infusion she was uncertain of the events of the previous day but was orientated. On day 2 she complained of a persistent headache. On day 4 she became febrile, hypotensive and oliguric and antibiotic treatment was commenced. Two days later she became unresponsive and had a rapidly dilating right pupil. The platelet count was 19 × 10 9 /l and a CT scan showed a large right frontal haemorrhagic infarct with extensive cerebral oedema. A craniotomy was performed but was unsuccessful and she died that night. No surgical tissue was sent for analysis and a post mortem was not performed.
Case 3
At the onset of therapy the creatinine level was 0.64 mmol/l and serum albumin was 20 g/l. Haemodialysis was commenced 2 days before he received his cells and was continued on a daily basis. Prior to the infusion of cells, vital signs were: temperature 38°C, pulse rate 120/min, BP 80/50 mmHg and oxygen saturation 94%. On completion of the infusion of the second bag of PBPC there was the sudden development of altered mental state associated with nystagmus to the right, deviation to the right of both eyes, a reduced gag reflex and bilateral Babinski reflexes. The pulse rate decreased from 120/min to 80/min but the BP remained stable. No ECG was taken. Dexamethasone 40 mg i.v. was given. CT scanning showed an area of slightly low attenuation in the deep white matter of the left frontal lobe, consistent with an early infarct in the left anterior cerebral artery territory. Two hours later his mental state improved but he remained confused and incontinent and had mild weakness in both arms and legs. The remaining cells (four additional bags of PBPC and three of BM) were infused the next day after premedication with promethazine 12.5 mg and dexamethasone 40 mg i.v. This infusion was complicated by chest tightness, atrial ectopics on ECG and decreased oxygen saturation. These changes resolved after 2 h. An echocardiogram on day 4 showed the left ventricle to be of normal size with hyperdynamic systolic function, and an enlarged left atrium. He continued to have slow speech and cognition. On day 7 a MRI demonstrated several small foci of decreased diffusion in both cerebral hemispheres involving multiple vascular territories, consistent with acute infarction. The regions involved were the right head of caudate, right insular cortex, left parietal subcortical white matter and right frontal cortex. He engrafted on day 11 but died of respiratory failure and sepsis on day 31. Post mortem examination revealed focal aspergillus with haemorrhagic infarction in the left frontal lobe; no macroscopic abnormalities were reported in the right frontal lobe and this was not examined microscopically. Aspergillus was also demonstrated in the myocardium and lungs.
Discussion
The temporal relationship of the neurological events in these cases to the stem cell infusion is consistent with a direct toxic effect of the infused product. The likelihood that impaired blood supply resulting in cerebral ischaemia was involved is suggested by the demonstration of CT changes of infarction in cases 2 and 3. In case 2, our interpretation is that the patient suffered a small cerebral infarct initially which was complicated by secondary haemorrhage in the context of thrombocytopenia. In case 3, the initial clinical picture was consistent with an acute delirium with brain stem dysfunction. Post mortem examination subsequently demonstrated cerebral aspergillosis, but the acute onset of neurological signs during the PBPC infusion and the subsequent improvement makes it unlikely that angioinvasive fungal infection was the only pathology involved. The first case was typical of transient global amnesia, the aetiology of which is uncertain but has been related to cerebral ischaemia 4 and migraine-related vasospasm. 5 No event occurred in the context of profound hypotension or bradyarrhythmias. This suggests that cerebral hypoperfusion due to cardiac dysfunction was not relevant. One possibility however, is that DMSO was involved. Local infusion of DMSO can cause acute vasospasm in swine, a minority of whom also had microscopic histopathologic changes suggestive of angiotoxicity. 6 Neurological toxicity due to i.v. DMSO administered in non-transplant settings has been reported. 7, 8 Yellowlees et al 7 described a woman who presented with drowsiness after treatment with i.v. DMSO for arthritis in whom a CT scan revealed a small left posterior cerebral infarct. The symptoms resolved over the next 48 h. Bond et al 8 described a patient treated with i.v. DMSO over a 3-week period for prostate cancer who became uncooperative and agitated with dysarthric speech and disorientation. The symptoms resolved over the subsequent 2 weeks.
While the pathophysiology remains unclear, these cases suggest that infusion of cryopreserved stem cell products may result in acute neurological toxicity secondary to cerebrovascular ischaemia.
